CPMP issues positive opinion reaffirming favorable risk/benefit profile of Reductil/Meridia July 2, 2002
ACAT inhibitor with promising hypocholesterolemic effects under investigation at Sumitomo July 2, 2002
E.U. approval of irbesartan for renal disease in hypertensive and type 2 diabetes patients July 1, 2002
RSS